-
The post holder will develop computational models of learning processes in cortical networks. The research will employ mathematical modelling and computer simulation to identify synaptic plasticity
-
. The group is well known for developing single-molecule and single-cell fluorescence methods (Uphoff PNAS 2013; Zagajewski, Nature Comm Biol 2023, Chatzimichail, Lab-on-a-chip 2024) and applying them
-
SECURE project, a major multi-partner programme developing self adaptive gene therapies for neurological disease. This will involve (1) producing a single nuclei atlas of the substantia nigra and (2
-
. Our group develops, validates and applies novel MRI techniques for basic and clinical neuroscience. This post will focus primarily on ex-vivo and in-vivo peripheral nerve imaging data, for ongoing
-
of working with quantitative data and relevant software (Stata, R, Python, or similar). This is a full-time, fixed-term post for 12 months, that must end no later than February 2027. The Department of Social
-
consumer education. The post requires 2 days on site per week in either Park End Street, Oxford (where the post is based) or London (to collect data at the funding company). The remaining 3 days can be home
-
relevant to setting a roadmap for ongoing experiments, as well as recently developed applications of tensor network techniques to large-scale partial differential equations. We are advertising two positions
-
About the role We are seeking a highly motivated and ambitious Postdoctoral Researcher. This position focuses on developing innovative cancer treatments, particularly within the field of antibody
-
NHS Foundation Trust. The post holder will be a member of the Retinal Disease and Repair Group (Xue Lab) with responsibility for carrying out research to develop advanced therapies for inherited
-
scientists, forming small teams focused on ambitious, ‘blue sky’ research for novel methods development relevant for drug discovery analysis pipelines, trial design and operational efficiency. Led by Professor